News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Schering AG Says German Rival Merck KGaA Plans $17.4 Billion Bid
March 13, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
In a move that could create a new European heavyweight in the global pharmaceuticals business, German drug maker Merck KGaA plans a takeover bid for rival Schering AG in a deal worth about $17.4 billion, but Schering said Sunday it's not enough.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Manufacturing
PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO
November 13, 2026
·
2 min read
·
Nick Paul Taylor
IPO
Windward nets $175M IPO, bringing 2026 biotech debuts to 35
November 13, 2026
·
1 min read
·
Gabrielle Masson
Venture capital
Neurosterix nabs $105M, recruits Karuna veterans for schizophrenia push
November 12, 2026
·
2 min read
·
Gabrielle Masson
Funding
Pfizer snags $1.5B financing from PE firm Blackstone to support Metsera asset
November 12, 2026
·
2 min read
·
Annalee Armstrong